PERTH, Australia – Industry stakeholders praised Australia's federal budget for 2018-2019, released late last week, because the government said it was seeing results from investments pumped into the medical technology and pharmaceuticals sector, and it will continue to invest more.
PERTH, Australia – Melbourne-based Starpharma Holdings Ltd. has entered a sales and marketing deal with Mundipharma International Ltd., which gives Mundipharma sales and marketing rights to Vivagel BV for bacterial vaginosis (BV) in Asia, the Middle East, Africa and the majority of Latin America.
PERTH, Australia – Melbourne-based Starpharma Holdings Ltd. has entered a sales and marketing deal with Mundipharma International Ltd., which gives Mundipharma sales and marketing rights to Vivagel BV for bacterial vaginosis (BV) in Asia, the Middle East, Africa and the majority of Latin America.
PERTH, Australia – Following its IPO on Australia's Securities Exchange in November, Aussie radiopharma company Telix Pharmaceuticals Ltd. has been building up global partnerships to prepare for a commercial build-up of its "theranostic" radiopharmaceuticals.
PERTH, Australia – Following its IPO on Australia's Securities Exchange in November, Aussie radiopharma company Telix Pharmaceuticals Ltd. has been building up global partnerships to prepare for a commercial build-up of its "theranostic" radiopharmaceuticals.
PERTH, Australia – Australia's Medical Technologies and Pharmaceuticals Industry Growth Centre (MTPConnect) and Biopacific Partners have launched a new program that will work with small Australian biotechs to better prepare them for partnering with big pharma.
